Detection of HIV-1 tat, rev and nef mRNA at single cell level. NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Detection of HIV-1 tat, rev and nef mRNA at single cell level.

Annu Conf Australas Soc HIV Med. 1993 Oct 28-30;5:104 (poster no. 59). Unique Identifier : AIDSLINE ASHM5/94348919
Peng H; Haase AT; National Centre for HIV Virology Research, Institute of Medical; and Veterinary Science, Adelaide, South Australia.


Abstract: We have developed a strategy of in situ hybridisation using splice-junction probes which can specifically detect HIV-1 regulatory and structural gene mRNAs. This approach takes advantage of the fact that although tat, rev and nef share the same 5' splice donor, they differ in their use of the first splice acceptors. Eukaryotic expression vectors containing HIV-1 tat, rev, nef, env and gag genes were constructed and used to transfect Cos, Raji and H9 cells. The expression of HIV-1 genes on each transfectant was verified by indirect immunofluorescence. The specificity of the 35S-labelled splice junction probes was tested against all the transfectants under different stringency conditions. The conditions of in situ hybridisation were optimized, achieving the best specificity and sensitivity. This technique was successfully applied to detect HIV-1 tat, rev, nef, env and gag/genomic RNA in HIV-1 infected cells.
Keywords: Cell Line Genes, gag/GENETICS Genes, nef/*GENETICS Genes, rev/*GENETICS Genes, tat/*GENETICS Human HIV-1/*GENETICS In Situ Hybridization RNA Splicing RNA, Messenger/*GENETICS Transfection/GENETICS ABSTRACTKWDcelllinegenes,gag/geneticsgenes,nef/KWDgeneticsgenes,rev/KWDgeneticsgenes,tat/KWDgeneticshumanhiv-1/KWDgeneticsinsituhybridizationrnasplicingrna,messenger/KWDgeneticstransfection/geneticsabstract
941230
M94C4308

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .